Analysis of Lipids in Human Milk at Different Gestational Ages
Study Details
Study Description
Brief Summary
Various studies have shown that the milk of a preterm infant differs from that of a term infant in the composition of micronutrients, vitamins, macronutrients, carbohydrates and proteins. The study of lipidomic is of particular interest because the role of fatty acids is known both as essential constituents of cell membranes and as molecules actively involved in energy metabolism. The study of human milk would offer the advantage of offering the best type of nutrition for the newborn at each specific period of life, in the event of a lack of mother's milk.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Mother's milk is the best food for the newborn as it is the only one capable of providing species-specific nutrition, guaranteeing everything necessary for the growth and maturation of a child. Mother's milk has the property of satisfying metabolic needs by changes in the composition of nutrients, which are different at each stage of life. Various studies have shown that the milk of a preterm infant differs from that of a term infant in the composition of micronutrients, such as vitamins, macronutrients, carbohydrates and proteins. The metabolomic study of human milk would offer the advantage of offering the best type of nutrition for the newborn at each specific period of life, in the event of a lack of mother's milk. This is particularly important in a Neonatal Intensive Care Unit, where it is essential to ensure timely adequate enteral nutrition. This is possible if a bank of donated human milk is available. The study of lipidomics is of particular interest, as the role of fatty acids is known both as essential constituents of cell membranes and as molecules actively involved in energy metabolism. Therefore, the benefit deriving from an adequate dietary intake in a constantly evolving organism such as that of a newborn is extremely important.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Women < 32 weeks of gestational age Women that delivered before 32 weeks of gestational age |
Other: Breastfeeding
Mothers will breastfeed their newborns
|
| Women between 32 and 36,6 weeks of gestational age Women that delivered between 32 and 36,6 weeks of gestational age |
Other: Breastfeeding
Mothers will breastfeed their newborns
|
| Women > 37 weeks of gestational age Women that delivered after 37 weeks of gestational age |
Other: Breastfeeding
Mothers will breastfeed their newborns
|
Outcome Measures
Primary Outcome Measures
- Quantification of essential long-chain polyunsaturated fatty acids in human milk [7 days after delivery]
To assess the concentrations of α-Linoleic acid (µg/mL) in human milk
- Quantification of essential long-chain polyunsaturated fatty acids in human milk [7 days after delivery]
To assess the concentrations of Eicosapentaenoic acid (µg/mL) in human milk
- Quantification of essential long-chain polyunsaturated fatty acids in human milk [7 days after delivery]
To assess the concentrations of Docosahexaenoic acid (µg/mL) in human milk
- Quantification of essential long-chain polyunsaturated fatty acids in human milk [7 days after delivery]
To assess the concentrations of Arachidonic acid (µg/mL) in human milk
- Quantification of essential long-chain polyunsaturated fatty acids in human milk [7 days after delivery]
To assess the concentrations of Linoleic acid (µg/mL) in human milk
Secondary Outcome Measures
- Quantification of essential long-chain polyunsaturated fatty acids in human milk [1 month after delivery]
To assess the concentrations of α-Linoleic acid (µg/mL) in human milk
- Quantification of essential long-chain polyunsaturated fatty acids in human milk [1 month after delivery]
To assess the concentrations of Eicosapentaenoic acid (µg/mL) in human milk
- Quantification of essential long-chain polyunsaturated fatty acids in human milk [1 month after delivery]
To assess the concentrations of Docosahexaenoic acid (µg/mL) in human milk
- Quantification of essential long-chain polyunsaturated fatty acids in human milk [1 month after delivery]
To assess the concentrations of Arachidonic acid (µg/mL) in human milk
- Quantification of essential long-chain polyunsaturated fatty acids in human milk [1 month after delivery]
To assess the concentrations of Linoleic acid (µg/mL) in human milk
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Mothers who have given birth in hospital at any gestational age
-
Written informed consent
-
BMI 18.50-24.99 Kg/m2
-
Varied and balanced maternal diet without restrictions
-
Weight gain during pregnancy up to 12kg
Exclusion Criteria:
-
Food intolerance
-
Celiac disease
-
Vegan or vegetarian diet
-
Diet with the exclusion of milk and derivatives
-
Diagnosis of metabolic diseases
-
Taking medicines during pregnancy
-
Withdrawal of informed consent
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Department of Pharmacy, University of Salerno | Salerno | Naples | Italy | 84084 |
| 2 | Department of Woman and Child, Buon Consiglio Fatebenefratelli Hospital | Napoli | Italy | 80123 |
Sponsors and Collaborators
- Ospedale Buon Consiglio Fatebenefratelli
- University of Salerno
Investigators
- Principal Investigator: Giuseppe De Bernardo, MD, Ospedale Buon Consiglio Fatebenefratelli
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 1669